Association of cooking oil fumes exposure with lung cancer: Involvement of inhibitor of apoptosis proteins in cell survival and proliferation in vitro

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 628, Issue 2, 2007, Pages 107-116

  Hung, Huey Shan ^a   Wu, Wen Jun ^b   Cheng, Ya Wen ^b   Wu, Tsu Chin ^c   Chang, Kee Lung ^a   Lee, Huei ^b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

2,4 DDE; Cell survival and proliferation; Cooking oil fumes (COF); Inhibitor of apoptosis proteins (IAPs); Lung cancer

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 2,4 DECADIENAL; ALDEHYDE DERIVATIVE; BENZO[A]PYRENE; CASPASE 3; CYCLIN DEPENDENT KINASE INHIBITOR 1; EDIBLE OIL; INHIBITOR OF APOPTOSIS PROTEIN 1; INHIBITOR OF APOPTOSIS PROTEIN 2; PROTEIN KINASE B; SURVIVIN; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL SURVIVAL; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; EXPOSURE; FLOW CYTOMETRY; FUME; HUMAN; HUMAN CELL; LUNG CANCER; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

AIR POLLUTION, INDOOR; ALDEHYDES; BENZO(A)PYRENE; CARCINOGENS; CELL PROLIFERATION; CELL SURVIVAL; COOKERY; DIETARY FATS, UNSATURATED; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; LUNG NEOPLASMS; SMOKE; TUMOR CELLS, CULTURED;

INTRACISTERNAL A-PARTICLES;

EID: 33847299414     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2006.12.005     Document Type: Article

References (48)

1. Ko Y.C., Cheng L.S., Lee C.H., Huang J.J., Huang M.S., Kao E.L., Wang H.Z., and Lin H.J. Chinese food cooking and lung cancer in women nonsmokers. Am. J. Epidemiol. 151 (2000) 140-147
2. Chen C.J., Wu H.Y., Chuang Y.C., Chang A.S., Luh K.T., Chao H.H., Chen K.Y., Chen S.G., Lai G..M., Huang H.H., et al. Epidemiologic characteristics and multiple risk factors of lung cancer in Taiwan. Anticancer Res. 10 (1990) 971-976
3. Gao Y.T., Blot W.J., Zheng W., Fraumeni J.F., and Hsu C.W. Lung cancer and smoking in Shanghai. Int. J. Epidemiol. 17 (1988) 277-280
4. Zhong L., Goldberg M.S., Parent M.E., and Hanley J.A. Risk of developing lung cancer in relation to exposure to fumes from Chinese-style cooking. Scand. J. Work Environ. Health 25 (1999) 309-316
5. Yang S.C., Jenq S.N., Kang Z.C., and Lee H. Identification of benzo[a]pyrene 7,8-diol 9,10-epoxide N2-deoxyguanosine in human lung adenocarcinoma cells exposed to cooking oil fumes from frying fish under domestic conditions. Chem. Res. Toxicol. 13 (2000) 1046-1050
6. Lin J.M., and Liou S.J. Aliphatic aldehydes produced by heating Chinese cooking oils. Bull. Environ. Contam. Toxicol. 64 (2000) 817-824
7. Fullana A., Carbonell-Barrachina A.A., and Sidhu S. Comparison of volatile aldehydes present in the cooking fumes of extra virgin olive, olive, and canola oils. J. Agric. Food Chem. 52 (2004) 5207-5214
8. Wu S.C., and Yen G..C. Effects of cooking oil fumes on the genotoxicity and oxidative stress in human lung carcinoma (A549) cells. Toxicol. In Vitro 18 (2004) 571-580
9. Chang L.W., Lo W.S., and Lin P. Trans, trans-2,4-decadienal, a product found in cooking oil fumes, induces cell proliferation and cytokine production due to reactive oxygen species in human bronchial epithelial cells. Toxicol. Sci. 87 (2005) 337-343
10. Lin S.Y., Tsai S.J., Wang L.H., Wu M.F., and Lee H. Protection by quercetin against cooking oil fumes-induced DNA damage in human lung adenocarcinoma CL-3 cells: role of COX-2. Nutr. Cancer 44 (2002) 95-101
11. Hung H.S., Wu W.J., Cheng Y.W., Wu M.F., Chang K.L., and Lee H. Cooking oil fumes improve lung adenocarcinoma cell survival through c-IAP2 induction. J. Toxicol. Environ. Health A 68 (2005) 1525-1535
12. Rothe M., Pan M.G., Henzel W.J., Ayres T.M., and Goeddel D.V. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 83 (1995) 1243-1252
13. Deveraux Q.L., Takahashi R., Salvesen G.S., and Reed J.C. X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388 (1997) 300-304
14. Deveraux Q.L., Leo E., Stennicke H.R., Welsh K., Salvesen G..S., and Reed J.C. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. Embo J. 18 (1999) 5242-5251
15. LeBlan A.C. Natural cellular inhibitors of caspases. Prog. Neuropsychopharmacol. Biol. Psychiatry 27 (2003) 215-229
16. Schimmer A.D. Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice. Cancer Res. 64 (2004) 7183-7190
17. Li F., Ackermann E.J., Bennett C.F., Rothermel A.L., Plescia J., Tognin S., Villa A., Marchisio P.C., and Altieri D.C. Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. Nat. Cell Biol. 1 (1999) 461-466
18. Galvan V., Kurakin A.V., and Bredesen D.E. Interaction of checkpoint kinase 1 and the X-linked inhibitor of apoptosis during mitosis. FEBS Lett. 558 (2004) 57-62
19. Samuel T., Okada K., Hyer M., Welsh K., Zapata J.M., and Reed J.C. cIAP1 localizes to the nuclear compartment and modulates the cell cycle. Cancer Res. 65 (2005) 210-218
20. Levkau B., Garton K.J., Ferri N., Kloke K., Nofer J.R., Baba H.A., Raines E.W., and Breithardt G. XIAP induces cell-cycle arrest and activates nuclear factor-kappaB: new survival pathways disabled by caspase-mediated cleavage during apoptosis of human endothelial cells. Cir. Res. 88 (2001) 282-290
21. Vivanco I., and Sawyers C.L. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat. Rev. Cancer 2 (2002) 489-501
22. Martelli A.M., Tazzari P.L., Tabellini G., Bortul R., Billi A.M., Manzoli L., Ruggeri A., Conte R., and Cocco L. A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells. Leukemia 17 (2003) 1794-1805
23. Neri L.M., Borgatti P., Tazzari P.L., Bortul R., Cappellini A., Tabellini G., Bellacosa A., Capitani S., and Martelli A.M. The phosphoinositide 3-kinase/AKT1 pathway involvement in drug and all-trans-retinoic acid resistance of leukemia cells. Mol. Cancer Res. 1 (2003) 234-246
24. Lin M.T., Lee R.C., Yang P.C., Ho F.M., and Kuo M.L. Cyclooxygenase-2 inducing Mcl-1-dependent survival mechanism in human lung adenocarcinoma CL1.0 cells: involvement of phosphatidylinositol 3-kinase/Akt pathway. J. Biol. Chem. 276 (2001) 48997-49002
25. Krystal G.W., Sulanke G., and Litz J. Inhibition of phosphatidylinositol 3-kinase-Akt signaling blocks growth, promotes apoptosis, and enhances sensitivity of small cell lung cancer cells to chemotherapy. Mol. Cancer Ther. 1 (2002) 913-922
26. Sithanandam G., Smith G.T., Fields J.R., Fornwald L.W., and Anderson L.M. Alternate paths from epidermal growth factor receptor to Akt in malignant versus nontransformed lung epithelial cells: ErbB3 versus Gab1. Am. J. Respir. Cell. Mol. Biol. 33 (2005) 490-499
27. Gao N., Zhang Z., Jiang B.H., and Shi X. Role of PI3K/AKT/mTOR signaling in the cell cycle progression of human prostate cancer. Biochem. Biophys. Res. Commun. 310 (2003) 1124-1132
28. Roz L., Gramegna M., Ishii H., Croce C.M., and Sozzi G. Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell lines. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 3615-3620
29. Lee J.G., Madden M.C., Reed W., Adler K., and Devlin R. The use of the single cell gel electrophoresis assay in detecting DNA single strand breaks in lung cells in vitro. Toxicol. Appl. Pharmacol. 141 (1996) 195-204
30. Mabuchi S., Ohmichi M., Nishio Y., Hayasaka T., Kimura A., Ohta T., Kawagoe J., Takahashi K., Yada-Hashimoto N., Seino-Noda H., Sakata M., Motoyama T., Kurachi H., Testa J.R., Tasaka K., and Murata Y. Inhibition of inhibitor of nuclear factor-kappaB phosphorylation increases the efficacy of paclitaxel in in vitro and in vivo ovarian cancer models. Clin. Cancer Res. 10 (2004) 7645-7654
31. Kiechle F.L., and Zhang X. Apoptosis: biochemical aspects and clinical implications. Clin. Chim. Acta 326 (2002) 27-45
32. Lee K.Y., Chang W., Qiu D., Kao P.N., and Rosen G.D. PG490 (triptolide) cooperates with tumor necrosis factor-alpha to induce apoptosis in tumor cells. J. Biol. Chem. 274 (1999) 13451-13455
33. Cummins J.M., Kohli M., Rago C., Kinzler K.W., Vogelstein B., and Bunz F. X-linked inhibitor of apoptosis protein (XIAP) is a nonredundant modulator of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human cancer cells. Cancer Res. 64 (2004) 3006-3008
34. Harlin H., Reffey S.B., Duckett C.S., Lindsten T., and Thompson C.B. Characterization of XIAP-deficient mice. Mol. Cell Biol. 21 (2001) 3604-3608
35. Zou T., Rao J.N., Guo X., Liu L., Zhang H.M., Strauch E.D., Bass B.L., and Wang J.Y. NF-kappaB-mediated IAP expression induces resistance of intestinal epithelial cells to apoptosis after polyamine depletion. Am. J. Physiol. Cell. Physiol. 286 (2004) C1009-C1018
36. Liu Z.M., Chen G.G., Ng E.K., Leung W.K., Sung J.J., and Chung S.C. Upregulation of heme oxygenase-1 and p21 confers resistance to apoptosis in human gastric cancer cells. Oncogene 23 (2004) 503-513
37. Huang H., Joazeiro C.A., Bonfoco E., Kamada S., Leverson J.D., and Hunter T. The inhibitor of apoptosis, cIAP2, functions as a ubiquitin-protein ligase and promotes in vitro monoubiquitination of caspases 3 and 7. J. Biol. Chem. 275 (2000) 26661-26664
38. Lee H.-Y., Srinvas H., Xia D., Lu Y., Superty R., LaPushin R., Gomez-Manzano C., Gal A.M., Walsh G.L., Force T., Ueki K., Mills G..B., and Kurie J.M. Evidence that phosphatidylinositol 3-kinase- and mitogen-activated protein kinase kinase-4/c-jun NH2-terminal kinase-dependent pathways cooperate to maintain lung cancer cell survival. J. Biol. Chem. 278 (2003) 23630-23638
39. Krasilnikov M.A. Phosphatidylinositol-3 kinase dependent pathways: the role in control of cell growth, survival, and malignant transformation. Biochemistry (Mosc) 65 (2000) 59-67
40. Shi D.Y., Deng Y.R., Liu S.L., Zhang Y.D., and Wei L. Redox stress regulates cell proliferation and apoptosis of human hepatoma through Akt protein phosphorylation. FEBS Lett. 542 (2003) 60-64
41. Mone A.P., Huang P., Pelicano H., Cheney C.M., Green J.M., Tso J.Y., Johnson A.J., Jefferson S., Lin T.S., and Byrd J.C. Hu1D10 induces apoptosis concurrent with activation of the AKT survival pathway in human chronic lymphocytic leukemia cells. Blood 103 (2004) 1846-1854
42. Malins D.C., Hellstrom K.E., Anderson K.M., Johnson P.M., and Vinson M.A. Antioxidant-induced changes in oxidized DNA. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 5937-5941
43. Li X.A., Bianchi C., and Sellke F.W. Rat aortic smooth muscle cell density affects activation of MAP kinase and Akt by menadione and PDGF homodimer BB. J. Surg. Res. 100 (2001) 197-204
44. Singhal S., Vachani A., Antin-Ozerkis D., Kaiser L.R., and Albelda S.M. Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review. Clin. Cancer Res. 11 (2005) 3974-3986
45. Jin M., Inoue S., Umemura T., Moriya J., Arakawa M., Nagashima K., and Kato H. Cyclin D1, p16 and retinoblastoma gene product expression as a predictor for prognosis in non-small cell lung cancer at stages I and II. Lung Cancer 34 (2001) 207-218
46. Chen W.J., Chang C.Y., and Lin J.K. Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip). Biochem. Pharmacol. 65 (2003) 1777-1785
47. Scott F.L., Denault J.B., Riedl S.J., Shin H., Renatus M., and Salvesen G.S. XIAP inhibits caspase-3 and -7 using two binding sites: evolutionarily conserved mechanism of IAPs. Embo J. 24 (2005) 645-655
48. Ferreira C.G., van der Valk P., Span S.W., Ludwig I., Smit E.F., Kruyt F.A.E., Pinedo H.M., van Tintren H., and Giaccone G. Expression of X-linked inhibitor of apoptosis as a novel prognostic marker in radically resected non-small cell lung cancer patients. Clin. Cancer Res. 7 (2001) 2468-2474